AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.
Another potential blockbuster just joined AbbVie's drug portfolio.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.